close

Global IT Outage Update

Every day we care for and treat hundreds of patients from Greater Manchester and beyond who come through our doors.

 

Today's global IT outage affected many organisations including ours but to put it into context, this outage affected less than a third of our patients.

 

Our staff worked tirelessly to deliver as many chemotherapy and immunotherapy treatments as possible and continue to finalise plans for those we were unable to see today due to issues affecting our supplier.

 

Thank you for being understanding and bearing with us. Unless our teams contact you, please attend for your appointment as planned.

 

We continue to work with our supplier to resolve this issue and prioritise our most clinically urgent patients. We apologise for any delays that have occurred as a result of this.

 

Any further updates will be published on our website and social media channels (Facebook and X/Twitter)

Skip to Content

A spotlight on early breast cancer

Tuesday 1 October 2024, 9am to 5pm BST

What to expect

This study day will focus on important new approaches to management of patients with early breast cancer. Topics will include all aspects of the patient pathway including surgery, endocrine, Immune and targeted therapies, radiotherapy and the prevention and management of treatment toxicities.

Intended audience

All health care professionals that work with breast cancer patients or who have an interest in breast cancer, including specialist registrars (SpRs) and consultant oncologists, GPs, community nurses, nurse specialists and research nurses.

Prices

Once early bird finishes

All tickets (on-site and virtual) include access to the event recordings, resources and presentations for up to 6 months post-event date.

Sign up for the A spotlight on early breast cancer study day on Eventbrite today

A spotlight on early breast cancer study day - Tuesday 1 October 2024

Time Session
9.15 Registration
10.00 Advances in breast radiotherapy
Dr Carmel Anandadas, Consultant Clinical Oncologist, The Christie NHS Foundation Trust
10.20 Recent advances In surgical management of the axilla
Mr Ashu Gandhi, Consultant Breast and Endocrine Surgeon, Manchester University Hospital NHS Trust
10.45 HER2 positive disease - Advances In HER2 positive breast cancer
Dr Ciara O’Brien, Consultant Medical Oncologist, The Christie NHS Foundation Trust

11.15 - break

Time Session
11.30 Immunotherapy in the management of early breast cancer
Dr Tim Robinson, Clinical Senior Lecturer in Medical Oncology, University of Bristol and Honorary Consultant Medical Oncologist, UHBW

12.30 - lunch

Time Session
13.15 Management of bone health in breast cancer patients
Dr Claire Higham, Consultant Endocrinologist, The Christie NHS Foundation Trust
13.40 Endocrine therapy side effects - Updates in management approaches
Mrs Nicola Stubbs, Senior Macmillan Clinical Nurse Specialist
14.05 Treatment of high-risk ER+ early breast cancer: Abemaciclib, Olaparib and beyond
Dr Caroline Wilson, Consultant Medical Oncologist, The Christie NHS Foundation Trust

14.30 - break

Time Session
15.00 Fertility and pregnancy in early breast cancer
Dr Anne Armstrong, Consultant Medical Oncologist, The Christie NHS Foundation Trust
15.30 Mainstream genetic testing and preventative therapy
Dr Sacha Howell, Clinical Senior Lecturer, University of Manchester and Honorary Consultant Medical Oncologist, The Christie NHS Foundation Trust

16.00 - close

Last updated: July 2024